Skip to main content
. Author manuscript; available in PMC: 2022 Mar 11.
Published in final edited form as: Int J Cancer. 2021 Jun 10;149(6):1302–1312. doi: 10.1002/ijc.33702

Figure 2.

Figure 2.

Three independent SNPs in mitotic phase-related pathway genes predict NSCLC survival. Kaplan-Meier (KM) survival curves for NSCLC patients of three identified SNPs and combined unfavorable genotypes in the PLCO trial: (A) 0, 1, 2, and 3 unfavorable genotypes in OS; (B) Dichotomized groups of the unfavorable genotypes into 0–1 and 2–3 in OS; (C) 0, 1, 2, and 3 unfavorable genotyes in DSS; (D) Dichotomized groups of the unfavorable genotypes into 0–1 and 2–3 in DSS.